Literature DB >> 8812422

Structure of the promoter and genomic organization of the human beta'-adaptin gene (BAM22) from chromosome 22q12.

M Peyrard1, H Q Pan, D Kedra, I Fransson, S Swahn, K Hartman, S W Clifton, B A Roe, J P Dumanski.   

Abstract

Adaptins are major structural components of heterotetrameric protein complexes called adaptors, which are essential in intracellular receptor transport via clathrin-coated vesicles. beta-adaptins constitute one of three known classes (alpha, beta, gamma) of adaptins, including beta and beta' subtypes. We previously cloned the human beta'-adaptin gene (BAM22) (GDB symbol, ADTB1) from chromosome 22q12 and proposed its involvement in the development of meningiomas. Here we describe the genomic organization of this gene, which consists of 22 exons spanning over approximately 100 kb. We also report results from point mutation screening of 7 randomly chosen exons analyzed in 110 sporadic meningiomas. As part of the genomic characterization of the BAM22 locus, we sequenced 40 kb covering exons 1-4 and 12 kb upstream from the start of gene transcription. Analysis of the sequence suggests that the BAM22 gene has a CG-rich promoter.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8812422     DOI: 10.1006/geno.1996.0431

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  3 in total

1.  Characterization of the mouse beta-prime adaptin gene; cDNA sequence, genomic structure, and chromosomal localization.

Authors:  C Guilbaud; M Peyrard; I Fransson; S W Clifton; B A Roe; N P Carter; J P Dumanski
Journal:  Mamm Genome       Date:  1997-09       Impact factor: 2.957

2.  Genomic landscape of meningiomas.

Authors:  Yohan Lee; Jason Liu; Shilpa Patel; Timothy Cloughesy; Albert Lai; Haumith Farooqi; David Seligson; Jun Dong; Linda Liau; Donald Becker; Paul Mischel; Soheil Shams; Stanley Nelson
Journal:  Brain Pathol       Date:  2009-11-20       Impact factor: 6.508

Review 3.  Gene expression profiling of meningiomas: current status after a decade of microarray-based transcriptomic studies.

Authors:  Mads Aarhus; Morten Lund-Johansen; Per Morten Knappskog
Journal:  Acta Neurochir (Wien)       Date:  2011-01-14       Impact factor: 2.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.